Background
Dr. Michael Holick, formerly Boston Medical Center’s chief of endocrinology, studied hypermobile Ehlers-Danlos syndrome and regularly testified in child-abuse proceedings. His view that the condition could help explain fractures in young children differed from the prevailing medical view and from conclusions reached by BMC clinicians. He complained internally that BMC physicians were failing to investigate the condition adequately, with potentially grave consequences for children and families. BMC later restricted his clinical privileges and his use of research evaluations in expert testimony, then terminated those privileges in 2021 after finding that he violated the restrictions. That action also ended his employment with the affiliated Evans Medical Foundation.
Holick sued for retaliation under the Massachusetts health-care whistleblower statute, General Laws chapter 149, section 187; breach of an asserted employment contract; and discharge in violation of public policy. The Superior Court rejected a discovery effort aimed at materials from the final peer-review proceeding and later entered summary judgment for BMC and the foundation on all claims. Holick appealed, challenging both the peer-review ruling and the merits judgment.
The Court’s Holding
The Appeals Court revived part of the whistleblower claim. Section 187(b)(4) protects a health-care worker who reports or complains about unsafe, dangerous, or potentially dangerous care. The court rejected BMC’s argument that this protection covers only formal or official reports. Holick’s 2016 email to BMC’s chief medical officer, alleging that a pediatric geneticist incompetently failed to explore a possible diagnosis and thereby contributed to a child’s removal from the family, could qualify. Evidence that BMC officials themselves recognized the harm of missing a genetic disorder was enough to make summary judgment improper on that theory. Other portions of the statutory claim remained dismissed, and the court left a limitations argument for further development on remand.
The panel also reinstated the common-law public-policy claim. Massachusetts statutes protect physicians from professional retaliation or restrictions because they testify as experts. The record could allow a jury to find that BMC extracted an agreement limiting Holick’s testimony about diagnoses or observations from his research and terminated him for violating that agreement. Even though the restriction did not ban every form of testimony, it could violate the statutory public policy protecting physician testimony, and a discharge based on it could therefore be actionable.
Other rulings favored BMC. The court affirmed dismissal of the contract claim and declined to disturb the discovery decision. Massachusetts broadly protects medical peer-review proceedings, reports, and records to encourage candid assessment of care. The statutory bad-faith exception is narrow and requires evidence that misconduct infected the review process itself, not merely a challenge to the grounds that prompted review. Holick did not show that the discovery judge abused her discretion. The court also noted, without deciding, whether the exception applies at all when no individual peer-review committee member is sued.
Key Takeaways
- A report or complaint under the Massachusetts health-care whistleblower law need not be formal or filed through an official channel to receive protection.
- An internal email about a single patient’s potentially dangerous care may support a claim under section 187(b)(4), even where other whistleblower provisions use different language.
- Employer restrictions tying a physician’s research activity to limits on expert testimony can support a wrongful-discharge claim grounded in Massachusetts public policy.
- The medical peer-review privilege remains formidable; attacking the reasons for initiating review is not enough to show bad faith within the process.
Why It Matters
The ruling is important for Massachusetts hospitals, academic medical centers, faculty practice plans, and clinicians. It gives section 187(b)(4) a practical reach suited to how safety concerns are often raised inside health systems: an email to senior management can be protected without the labels or mechanics of a formal grievance. Employers assessing discipline should therefore examine whether informal communications concern dangerous patient care and whether the proposed action could appear retaliatory.
The public-policy holding also matters at the intersection of employment, research, and litigation. Medical institutions may regulate clinical privileges and research protocols, but contractual limits connected to a physician’s expert testimony can implicate specific statutory protections. At the same time, the decision preserves confidentiality for genuine peer review. On remand, the surviving claims will turn on causation, timing, and the exact role Holick’s reports and testimony played in the termination—not on access to the privileged record of the final peer-review deliberations.